Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming.
Saved in:
| Title: | Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming. |
|---|---|
| Authors: | Wang Z; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Zhou Z; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Yang S; Department of Pediatric Urology, Guangzhou Medical University Affiliated Women and Children's Medical Center, Guangzhou, Guangdong, China., Zhao Z; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China., Li X; The First Clinical College of Zhengzhou University, Zhengzhou University, Zhengzhou, China., Liu X; Department of Obstetrics and Gynecology, Xinyang Central Hospital, Xinyang, Henan, China., Cheng G; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Xu R; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Li Q; Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Xing D; Department of Emergency Intensive Care Unit (ICU), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 30; Vol. 17, pp. 1777092. Date of Electronic Publication: 2026 Jun 30 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1777092 |
